A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-7117 in Healthy Subjects

Inclusion Criteria: * Healthy and free from clinically significant illness or disease * Male or female subjects aged 18 to 55 years or elderly male subjects aged ≥65 * A body weight of ≥60 kg for males and ≥50 kg for females, and a body mass index ranging from 18 to 30 kg/m2 Exclusion Criteria: * Participated in more than three clinical studies involving administration of an IMP in the previous year, or any study within 12 weeks * Clinically significant endocrine, thyroid, hepatic, respiratory, gastro intestinal, renal, cardiovascular or skin disease, or history of any significant psychiatric/psychotic illness disorder * Clinically relevant abnormal medical history, physical findings or laboratory values